Clinical Trials Update: Dec. 20, 2004
Gastroesophageal Reflux Disease (GERD) Lung Cancer Macular Degeneration
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
Gastroesophageal Reflux Disease (GERD)
A research study to assess the safety and efficacy of an investigational medication for people with heartburn (also known as gastroesophageal reflux disease or GERD). Volunteers 18 to 65 who have at least a three-month history of heartburn may be eligible. Research site located in Tucson, Ariz.
A research study of a combination of medications for the treatment of non-small cell lung cancer. Volunteers who have been diagnosed with non-squamous cell non-small cell lung cancer (stage IIIB disease with pleural effusion OR stage IV disease) whose cancer is recurrent or refractory may be eligible. Research sites located throughout the United States.
A research study to evaluate the safety and effectiveness of an investigational drug in patients, at least 50 years old, with a degenerative eye disease known as wet age-related macular degeneration (AMD). Research site located in Tampa, Fla.
Copyright 2004 CenterWatch. All rights reserved.